Anakinra biosimilar (AXXO)

阿那白滞素生物类似药(AXXO)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnakinra biosimilar (AXXO)
Drug Alias Name阿那白滞素生物仿制药(AXXO)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAxxo
China Registration ClassN/A

Develop Information

Active CompaniesAxxo
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL04AC03
Related LinksN/A